Proposal for Modified Alpha Fetoprotein Use in Hepatocellular Carcinoma Surveillance: Analysis of the 2018–2020 National Cancer Screening Program
Open Access
- 1 January 2026
- journal article
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (18) , e137
Abstract
Yu S, et al. J Korean Med Sci. 2026 May;41:e137. https://doi.org/10.3346/jkms.2026.41.e137Keywords
Funding Information
- Asan Institute for Life Sciences, Asan Medical Center (2025IP0046-1)
- National Research Foundation of Korea (RS-2024-00335644)
This publication has 37 references indexed in Scilit:
- Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With CirrhosisClinical Gastroenterology and Hepatology, 2023
- Detecting Early Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Using Longitudinal α-Fetoprotein ScreeningClinical Gastroenterology and Hepatology, 2022
- International trends in hepatocellular carcinoma incidence, 1978–2012International Journal of Cancer, 2019
- Harms of Hepatocellular Carcinoma SurveillanceCurrent Hepatology Reports, 2019
- Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the USThe American Journal of Medicine, 2017
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 updateHepatology International, 2017
- MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular CarcinomaJAMA Oncology, 2017
- Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening AlgorithmClinical Gastroenterology and Hepatology, 2016
- Improving Screening for Hepatocellular Carcinoma by Incorporating Data on Levels of α-Fetoprotein, Over TimeClinical Gastroenterology and Hepatology, 2013
- Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicitiesHepatology, 2010